TG Therapeutics Inc (TGTX)
13.51
-0.40
(-2.88%)
USD |
NASDAQ |
Apr 26, 11:42
TG Therapeutics Gross Profit (TTM): 219.53M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 219.53M |
September 30, 2023 | 183.49M |
June 30, 2023 | 21.28M |
March 31, 2023 | 7.686M |
December 31, 2022 | 2.519M |
September 30, 2022 | 4.553M |
June 30, 2022 | 6.199M |
March 31, 2022 | 7.025M |
December 31, 2021 | 5.90M |
September 30, 2021 | 3.827M |
June 30, 2021 | 2.127M |
March 31, 2021 | 0.768M |
December 31, 2020 | 0.152M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.152M
Minimum
Dec 2020
219.53M
Maximum
Dec 2023
35.77M
Average
5.90M
Median
Dec 2021
Gross Profit (TTM) Benchmarks
Amicus Therapeutics Inc | 362.03M |
Geron Corp | -- |
Editas Medicine Inc | -- |
G1 Therapeutics Inc | 75.32M |
Mersana Therapeutics Inc | -- |